September 2, 2015 — An investigational material known as Bioabsorbable Cardiac Matrix (BCM), designed to prevent cardiac ...
January 16, 2015 — Bellerophon Therapeutics LLC said it completed enrollment of its PRESERVATION I clinical trial of ...